Literature DB >> 19076250

Septic injury-inducible genes in medicinal maggots of the green blow fly Lucilia sericata.

B Altincicek1, A Vilcinskas.   

Abstract

Lucilia sericata maggots are used world-wide in biosurgery for the medical treatment of nonhealing wounds because they ingest necrotic tissues and significantly promote healing. To gain further insight into interdependencies between ecological adaptation and molecular evolution of innate immunity in Diptera, we used the suppression subtractive hybridization method to screen for genes that are differentially expressed in response to septic wounding of sterile second instar larvae of L. sericata. This approach resulted in the identification of 65 novel Lucilia genes including potential signalling proteins (e.g. inhibitor of apoptosis 2 protein) and a number of digestive enzymes including lipases and proteinases. Additionally, we found numerous putative antimicrobial peptides (AMPs), such as a potential Lucilia defensin, diptericin and three novel proline-rich AMPs. The identified genes may facilitate access to both peptides and proteins within the beneficial excretions, secretions and haemolymph of medicinal maggots and provide novel insights into the evolution of innate immunity in Diptera.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19076250     DOI: 10.1111/j.1365-2583.2008.00856.x

Source DB:  PubMed          Journal:  Insect Mol Biol        ISSN: 0962-1075            Impact factor:   3.585


  17 in total

Review 1.  [Biosurgical débridement using Lucilia sericata-maggots - an update].

Authors:  Pietro Nenoff; Antonia Herrmann; Christina Gerlach; Jürgen Herrmann; Jan Christoph Simon
Journal:  Wien Med Wochenschr       Date:  2010-08-16

2.  Insect-derived cecropins display activity against Acinetobacter baumannii in a whole-animal high-throughput Caenorhabditis elegans model.

Authors:  Elamparithi Jayamani; Rajmohan Rajamuthiah; Jonah Larkins-Ford; Beth Burgwyn Fuchs; Annie L Conery; Andreas Vilcinskas; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

3.  A novel approach to the antimicrobial activity of maggot debridement therapy.

Authors:  Anders S Andersen; Dorthe Sandvang; Kirk M Schnorr; Thomas Kruse; Søren Neve; Bo Joergensen; Tonny Karlsmark; Karen A Krogfelt
Journal:  J Antimicrob Chemother       Date:  2010-06-11       Impact factor: 5.790

4.  Lucifensin, the long-sought antimicrobial factor of medicinal maggots of the blowfly Lucilia sericata.

Authors:  Václav Cerovský; Jan Zdárek; Vladimír Fucík; Lenka Monincová; Zdenek Voburka; Robert Bém
Journal:  Cell Mol Life Sci       Date:  2009-11-18       Impact factor: 9.261

5.  Suppression subtractive hybridization (SSH) combined with bioinformatics method: an integrated functional annotation approach for analysis of differentially expressed immune-genes in insects.

Authors:  Chandan Badapanda
Journal:  Bioinformation       Date:  2013-02-21

6.  Next generation sequencing based transcriptome analysis of septic-injury responsive genes in the beetle Tribolium castaneum.

Authors:  Boran Altincicek; Abdelnaser Elashry; Nurper Guz; Florian M W Grundler; Andreas Vilcinskas; Heinz-Wilhelm Dehne
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

7.  Selection and Evaluation of Tissue Specific Reference Genes in Lucilia sericata during an Immune Challenge.

Authors:  Andre Baumann; Rüdiger Lehmann; Annika Beckert; Andreas Vilcinskas; Zdeněk Franta
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

8.  Lucifensins, the Insect Defensins of Biomedical Importance: The Story behind Maggot Therapy.

Authors:  Václav Ceřovský; Robert Bém
Journal:  Pharmaceuticals (Basel)       Date:  2014-02-27

Review 9.  Mechanisms of maggot-induced wound healing: what do we know, and where do we go from here?

Authors:  Ronald A Sherman
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-13       Impact factor: 2.629

Review 10.  Recent advances in developing insect natural products as potential modern day medicines.

Authors:  Norman Ratcliffe; Patricia Azambuja; Cicero Brasileiro Mello
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-06       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.